Statin-associated exacerbation of myasthenia gravis

被引：46

作者：

Cartwright, MS ^{[1
]}

Jeffery, DR ^{[1
]}

Nuss, GR ^{[1
]}

Donofrio, PD ^{[1
]}

机构：

[1] Wake Forest Univ, Baptist Med Ctr, Sch Med, Dept Neurol, Winston Salem, NC 27157 USA

来源：

NEUROLOGY | 2004年 / 63卷 / 11期

关键词：

D O I：

10.1212/01.WNL.0000145708.03876.C3

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

[No abstract available]

引用

页码：2188 / 2188

页数：1

共 6 条

[1] Reversible ocular myasthenia gravis or mitochondrial myopathy from statins? [J].

Engel, WK .

LANCET, 2003, 361 (9351) :85-86

[2] Statins and myopathy [J].

Hargreaves, IP ;

Heales, S .

LANCET, 2002, 359 (9307) :711-712

[3] T cells and cytokines in the pathogenesis of acquired myasthenia gravis [J].

Milani, M ;

Ostlie, N ;

Wang, W ;

Conti-Fine, BM .

MYASTHENIA GRAVIS AND RELATED DISORDERS: BIOMCHEMICAL BASIS FOR DISEASE OF THE NEUROMUSCULAR JUNCTION, 2003, 998 :284-307

[4] Statins, fibrates, and ocular myasthenia [J].

Parmar, B ;

Francis, PJ ;

Ragge, NK .

LANCET, 2002, 360 (9334) :717-717

[5] The lipid and non-lipid effects of statins [J].

Wierzbicki, AS ;

Poston, R ;

Ferro, A .

PHARMACOLOGY & THERAPEUTICS, 2003, 99 (01) :95-112

[6] The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease [J].

Youssef, S ;

Stüve, O ;

Patarroyo, JC ;

Ruiz, PJ ;

Radosevich, JL ;

Hur, EM ;

Bravo, M ;

Mitchell, DJ ;

Sobel, RA ;

Steinman, L ;

Zamvil, SS .

NATURE, 2002, 420 (6911) :78-84

← 1 →